Protean eGov Technologies Limited has submitted to the Exchange, the Outcome of Board Meeting held on August 6, 2025

Related-party transactionsExceptional itemResults View source PDF Explain this filing

PROTEAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.7%Reaction day

₹759.90

prior close

₹764.25

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%+2.0% vs market

IT Enabled Services peers, median of 63sector+0.3%+1.4% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 1.4 pts more than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.6

15m

+1.4

30m

+2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.7-0.3+2.0+0.3+1.4

Next day

-2.3-1.2-1.1-0.7-1.6

-4.9-1.0-4.0-0.8-4.1

-5.3-1.0-4.3-0.5-4.8

-3.3-0.3-3.0-0.5-2.8

-3.3-1.1-2.2-0.3-3.0

-0.3+1.6-2.0+0.5-0.8

15d

+14.3-0.2+14.5-0.2+14.4

+18.8+1.4+17.5+1.0+17.8

+14.6+0.2+14.4-2.5+17.1

+11.3+0.9+10.4-1.4+12.7

UpDownMarket · Nifty Microcap 250Sector · IT Enabled Services peers, median of 63Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Protean eGov Technologies reported its Q1 FY26 (quarter ended June 30, 2025) standalone results, with revenue from operations at ₹209.98 Cr vs ₹196.19 Cr in Q1 FY25 (~7% growth). Total income stood at ₹238.59 Cr, and profit after tax was ₹26.50 Cr vs ₹21.71 Cr in the same quarter last year (~22% growth), helped by a ₹5.76 Cr write-back of employee benefit provisions included in other income. Profit before tax grew ~26% to ₹35.02 Cr. On a consolidated basis, revenue was ₹210.84 Cr and PAT was ₹23.85 Cr, with four subsidiaries (not material) contributing a loss of ₹2.63 Cr. The Board also approved an additional equity infusion of up to ₹19 Cr into its wholly-owned Dubai-based subsidiary Protean International DMCC to fund international business expansion.

Likely market impact

The results show steady revenue growth and meaningful bottom-line improvement, though the PAT boost was partly aided by a one-time provision write-back. The ₹19 Cr investment signals the company's intent to expand internationally through its Dubai arm, which is a related-party transaction done at arm's length. Overall, a stable quarter with modest growth and a strategic capital allocation move.